|
|
Home >
Anti-aging Research > Triiodothyronine [T3]
Liothyronine/Cytomel®/Triiodothyronine [T3]
News & Research:
-
Worsening HFpEF Linked
With Low T3/T4 Ratio - Medscape, 10/6/22 - "Among
those whose ratio of free triiodothyronine (FT3) to free thyroxine (FT4) was in
the lowest tertile, there was a significantly increased rate of a composite of
urgent heart failure (HF) visits involving diuretic intensification, HF
hospitalization, or cardiovascular death compared with those whose ratios were
in the higher tertiles" - Note: I seen other studies to support this but
I doubt if doctors are current on it. Getting a prescription that includes T3 is
like trying to get a prescription for cocaine.
-
an a Commonly Prescribed
Thyroid Medication Lift Depression and Dementia? - Medscape, 12/16/21 -
"While the therapeutic advantages and disadvantages over
replacement with pure levothyroxine [T4] or a mixture of T4 with
triiodothyronine [T3] have generated a consensus in favor of levothyroxine
alone, we still grapple with treated patients who complain of impaired
well-being ... Despite thyroid hormone replacement's clinical use for over 100
years and levothyroxine monotherapy for about 50 years, when to use a mixture,
if ever, remains contentious despite numerous comparison trials ... A recent
trial sponsored by the US military perhaps offers the branch point that affects
prescribing. The group studied about 75 people with established hypothyroidism
that was corrected to normal TSH with medication. They also administered a
variety of quality-of-life and skill measurements. Using a crossover design,
they identified people who scored poorly on the quality-of-life assessment when
taking levothyroxine alone, and then offered a T3-containing alternative, and
saw the quality-of-life score improve. But again, measurements of well-being and
a few cognitive symptoms remained mostly independent of the type of thyroid
hormone that produced the therapeutic TSH"
-
Combo Thyroid Hormones as
Good as Levothyroxine for Hypothyroidism - Medscape, 3/22/21 -
"Patients with hypothyroidism treated with the three
most common pharmacological strategies of levothyroxine (LT4) alone, LT4 in
combination with triiodothyronine (T3), or desiccated thyroid extract showed no
differences in thyroid symptoms or secondary outcomes in a double-blind
randomized study ... Additionally, some patients treated with LT4 alone report
greater improvements in symptoms with the addition of T3 ... Overall, 45% of
patients indicated they preferred desiccated thyroid as their first choice of
treatment, 32% preferred LT4/T3 as their first choice, and 23% preferred LT4
alone ... When Switched to Desiccated Thyroid, Many Felt 'Much Better' ... A
further exploratory analysis revealed that those who experienced symptoms while
taking LT4 alone reported greater alleviation of symptoms with the other two
treatments ... However, with the subgroup analysis based on the scores of
symptom questionnaires, we found that symptomatic patients on LT4 improved while
being treated with LT4/T3 or desiccated thyroid ... Reports of improvements in
switching to desiccated thyroid were notable, Hoang added. "Many patients when
switched from LT4 to desiccated thyroid extract said they felt much better,
[with] more energy, less mental fogginess, a better outlook, less flair of lupus
symptoms, easier to lose weight, etc."" - Note: So why is trying to
get a prescription for desiccated thyroid extract or a t4/t3 combo like trying
to get a prescription for cocaine? Lotta old-timer endocrinologists think
they know it all when the research doesn't back them up.
-
New Trials on T3/T4
Combination for Hypothyroidism 'Justified' - Medscape, 3/2/21 -
"There was sufficient justification for new trials of
our current T3 preparation based on the fact that the trials were underpowered
and had other issues, such as not selecting patients with residual symptoms,
short duration of the study, and once-daily dosing of T3"
-
Serum Triiodothyronine-to-thyroxine
(T3/T4) Ratio Predicts Therapeutic Outcome to Biological Therapies in Elderly
IBD Patients - Medscape, 2/1/21 - "Baseline T3/T4
ratio was higher in patients with mucosal healing, as compared with those
without mucosal healing (P < 0.0001), regardless of the disease type or
biological drug (OR 6.4 [2.9–14.3] for each T3/T4 unit increase, P < 0.0001). A
cut point of 3.3 was identified as the optimal threshold of baseline T3/T4 ratio
for predicting mucosal healing, providing 78% sensitivity and 89% specificity
(area under the ROC curve 0.88 [0.79–0.94]; positive and negative likelihood
ratios 6.8 [2.9–15.9] and 0.3 [0.1–0.5] respectively) ... T3/T4 ratio seems a
reliable tool for predicting therapeutic outcome of biological therapy in
elderly patients with IBD"
-
Armour Thyroid (USP) and combined thyroxine/ tri-iodothyronine as Thyroid
Hormone - british-thyroid-association.org, Feb 2007 -
"Thyroid contains both thyroxine (T4) and tri-iodothyronine
(T3) extracted from the thyroid gland of pigs. One grain, about 60 mg, of
desiccated pig thyroid extract contains about 38mcg of T4 and 9mcg of T3, a
ratio of around 4 to 1. The normal concentration of these hormones in the human
thyroid is, however, at a ratio of 14 to 1"
-
Can 'Normal' T4 Levels
Increase AF Risk? - Medscape, 12/11/18 - "After
adjustment, the relative risk for prevalent AF in the highest normal free T4
quartile group was double that of the lowest group. No similar associations were
seen between the quartiles for free T3. Thyroid-stimulating hormone (TSH)
results were mixed."
-
The Love-Hate Relationship
With Levothyroxine - Medscape, 10/25/18 - "Some
might have a preference for animal-derived, nonsynthetic, natural forms of
treatment, such as desiccated thyroid extract (DTE) from bovine and porcine
sources, which contain both T3 and T4 at an approximate physiologic ratio of 1:4
... I discuss with these patients that the physiologic ratio of T3:T4 secretion
by the thyroid gland in humans is approximately 1:14.[4] In contrast, the makeup
of DTE is approximately 1:4; thus, there is a relatively higher proportion of T3
than T4 in animal-derived sources of thyroid hormone ... Given the potential
risks for cardiac arrhythmias and worsened bone health associated with perhaps
any T3 therapy, I offer two separate prescriptions for synthetic T3 and T4 as
the initial step to hypothyroid individuals who strongly prefer trying T3. To
best replicate the physiologic ratio of T3:T4 production, the separate
prescriptions should be about 1:13-1:20 that of T3 to T4 ... T3 also has a much
shorter half-life than T4; thus, twice-daily dosing may be best. For example, an
individual who has been taking 112 µg of synthetic T4 once daily and wants to
try incorporating T3 would be prescribed 5 µg of synthetic T3 twice daily
combined with 100 µg of synthetic T4 to reach a total of 110 µg of thyroid
hormone per day, which is as close to the previous weight-based dose as
possible"
-
Chronic Fatigue Syndrome
Linked to Low T3 Syndrome - Medscape, 3/29/18 -
"Some people with the condition known as chronic fatigue syndrome (CFS) have low
circulating levels of the thyroid hormone triiodothyronine (T3) and normal
levels of thyroid-stimulating hormone (TSH) ... This low T3 syndrome might be in
line with recent metabolomic studies that point to a hypometabolic state (Proc
Natl Acad Sci U S A.
2016;113:E5472-E5480), and if confirmed, T3 and iodide supplements may be
indicated as treatments, say Núñez and colleagues"
-
Chronic
fatigue syndrome possibly explained by lower levels of key thyroid hormones
- Science Daily, 3/20/18 - "In hypothyroidism, the body
tries to encourage thyroid hormone activity by releasing more
thyroid-stimulating hormone -- however, this does not happen in patients with
chronic fatigue syndrome ... the researchers compared thyroid function and
markers of inflammation between 98 CFS patients and 99 healthy controls.
Remarkably, the CFS patients had lower serum levels of certain key thyroid
hormones such as triiodothyronine (T3) and thyroxine (T4), but normal levels of
thyroid-stimulating hormone ... Additional analyses indicated that CFS patients
had a lower urinary iodine status and low-grade inflammation, which possibly
mirrored the symptoms of patients with hypothyroidism. These CFS patients,
however, had relatively higher levels of another thyroid hormone called "reverse
T3" or rT3. This appeared to be due to a shift in hormone production, where the
body preferred to convert T4 to rT3 instead of producing T3. The low T3 levels
found in CFS patients coupled with this switchover to rT3 could mean that T3
levels are severely reduced in tissue"
-
Symptoms Persist Despite
Normalized TSH With Levothyroxine - Medscape, 10/25/16 -
"Despite having normal blood levels of
thyroid-stimulating hormone (TSH), many patients treated for hypothyroidism with
levothyroxine (L-T4) continue to have symptoms, including fatigue as well as a
higher body mass index (BMI) and a greater likelihood of antidepressant and
beta-blocker use, compared with healthy controls ... for the first time, we have
documentation that supports the patients' complaints, demonstrating that…[this]
was not only in their minds, as some have suggested ... those in the
L-T4–treatment group had approximately 10% to 15% higher total and free
thyroxine (T4) levels and about 5% to 10% lower serum and total triiodothyronine
(T3) levels compared with the healthy controls ... And the serum T3:T4 ratios in
the L-T4–treated group were approximately 15% to 20% lower than in the healthy
matched controls ... Also, compared with the healthy controls, those in the L-T4
group had major differences in seven of 21 objective parameters, including BMI
(P < .001), total cholesterol (P < .01), HDL cholesterol (P = .02). and LDL
cholesterol (P = .03); and in use of beta-blockers (P < .0001), statins, and
antidepressants ... those taking L-T4 weighed approximately 10 pounds more than
healthy controls of the same height, despite consuming fewer calories ...
"Endocrinologists have accepted and propagated the notion that blood T3 levels
are 'normal' in hypothyroid patients treated with levothyroxine," Dr Bianco
noted ... Yet there are "are a handful of relatively recent studies indicating
this is not the case," of which "ours is the most recent one, confirming that
serum T3 is lower in these patients."
-
To T3 or Not: Combo Therapy
in Hypothyroidism - Medscape, 12/18/14 - "One theory
as to why some patients may indeed continue to experience hypothyroid symptoms
such as fatigue, weight gain, and "brain fog" despite achieving normal TSH
levels with L-T4 monotherapy was recently proposed with the discovery of common
variations in the deiodinase 2 (DIO2) gene ... The latter was found to be
associated with reduced ability to convert T4 to T3, potentially leading to a
lack of response to monotherapy with T4 ... I suggest Armour to patients because
it's economical and it's simple ... One problem with combination therapy [with
synthetic T4 and T3] is that people find it to be very hard to take three pills
a day, and you only have to take one Armour ... Furthermore, the synthetic T3 is
very expensive, so I'm really looking at it from a more practical point of view
... After a minimum of 4 weeks on Armour, 78% expressed a preference for Armour
compared with L-T4, with no serious adverse events noted, even with 30 of the
subjects aged 65 years or older ... The [different] study involved 70 patients,
aged 18 to 65, who were treated for 16 weeks with either desiccated-thyroid
extract or L-T4 and then crossed over for the same duration ... Patients treated
with desiccated thyroid had an average weight loss of 3 lb, and there was no
difference in thyroid-function blood tests between the two groups after
treatment ... Regarding the theory that it could be dangerous — where are the
case reports of people getting sick? You will not find a single scientific paper
stating any real danger from desiccated thyroid, and as far as I'm concerned,
the [medical societies] are scaring people away from this"
-
Low
thyroid levels may signal heightened risk of death in hospitalized patients
- Science Daily, 10/30/13 - "When older individuals have
low levels of thyroid hormones, particularly T3, it reflects that the body is
weak and more susceptible to the harmful effects of disease ... As a result,
older individuals who have a reduced ability to synthesize T3 hormones have a
higher rate of mortality, both in the short- and long-term"
-
Persistence
of Mortality Risk in Patients With Acute Cardiac Diseases and Mild Thyroid
Dysfunction - Am J Med Sci. 2011 Aug 26 - "A total
of 1026 patients (mean age: 67.7 years) were divided into 4 groups: (1)
euthyroid (EU, n = 579); (2) subclinical-like hypothyroidism (SLHYPO, n = 68);
(3) subclinical-like hyperthyroidism (SLHYPER, n = 23) and (4)
low-triiodothyronine syndrome (LowT3, n = 356). Follow-up started from the day
of thyroid hormone evaluation (mean follow-up: 30 months). The events considered
were cardiac and overall deaths ... Survival rate for cardiac death was lower in
SLHYPO and in LT3 than in EU (log rank test; χ = 33.6; P < 0.001). Survival rate
for overall death was lower in SLHYPO, SLHYPER and LowT3 than in EU (48.3; P <
0.001). After adjustment for several risk factors, the hazard ratio for cardiac
death was higher in SLHYPO (3.65; P = 0.004) in LowT3 (1.88; P = 0.032) and in
SLHYPER (4.73; P = 0.047). Hazard ratio for overall death was higher in SLHYPO
(2.30; P = 0.009), in LowT3 (1.63; P = 0.017) and in SLHYPER than in EU (3.71; P
= 0.004). Hazards for SLHYPO, SLHYPER and LowT3 with respect to EU were
proportional over the follow-up period ... In patients with acute cardiac
disease, a mildly altered thyroid status was associated with increased risk of
mortality that remains constant during all the follow-up"
-
Antipsychotics Significantly Decrease Free Thyroid Hormone Concentrations
- Doctor's Guide, 9/4/08 - "In patients who receive
antipsychotic medication, levels of free thyroxine and free triiodothyronine
show significant decreases that may affect thyroid hormone functional
activity in some tissues, such as the liver"
-
Best Thyroid Treatment? - Dr. Weil, 8/29/08
-
Looking For The Fountain Of Youth? Cut Your Calories, Research Suggests
- Science Daily, 7/3/08 - "While scientists do not
know how calorie restriction affects the aging process in rodents, one
popular hypothesis is that it slows aging by decreasing a thyroid hormone,
triiodothyronine (T3), which then slows metabolism and tissue aging"
- All the studies I've read seem to support the opposite:
-
Longer-lived Rodents Have Lower Levels Of Thyroid Hormone - Science
Daily, 10/12/06 - "T4 levels varied significantly
between all of the groups, with the shorter-lived groups having higher
levels of T4 than longer-lived groups ... However, because T3, levels did
not differ significantly among all the groups, further research in this area
using larger sample sizes (numbers of rodents in each group) is needed"
-
ACUTE EFFECTS OF TRIIODOTHYRONINE REPLACEMENT THERAPY IN PATIENTS WITH
CHRONIC HEART FAILURE AND LOW-T3 SYNDROME: A RANDOMIZED, PLACEBO-CONTROLLED
STUDY - J Clin Endocrinol Metab. 2008 Jan 2 -
"Low-triiodothyronine (T3) syndrome is a predictor of poor outcome in
patients with cardiac dysfunction ... dilated cardiomyopathy (DC) ... In DC
patients, short-term synthetic L-T3 replacement therapy significantly
improved neuroendocrine profile and ventricular performance"
-
Low triiodothyronine: a strong predictor of outcome in acute stroke patients
- Eur J Clin Invest. 2007 Aug;37(8):651-7 - "The
1-year mortality was 27.34% for low T3 and 19.37% for normal T3 cases (P =
0.006). A smaller percentage of patients with low T3 values were independent
at 1 year compared to those with normal T3 values [54.2% vs. 68.7%, chi(2) =
12.09, P < 0.001, odds ratio (OR) = 0.53"
-
Natural killer activity and thyroid hormone levels in young and elderly
persons - Gerontology 2001 Sep-Oct;47(5):282-8 -
"Decreased serum concentrations of total T(3) may
contribute to low NK activity in the 'almost healthy' subgroup of the
elderly"
-
Does low tri-iodothyronine independently predict mortality in elderly
hospitalised patients? - Int J Clin Pract 2001 Jul-Aug;55(6):409-10 -
"Our study shows an association of low serum T3 with
patient mortality in elderly hospitalised patients"
-
T3 Supplementation Raises Patients' Response to Sertraline - Clinical
Psychiatry News, 11/06 - "The sertraline-T3 cohort
also was much more likely (odds ratio 2.69) to go into remission by the
sixth week of treatment. At that point, 58.5% (31/53) of the T3-augmented
patients but only 38% (19/50) of the placebo group was in remission"
-
Longer-lived Rodents Have Lower Levels Of Thyroid Hormone - Science
Daily, 10/12/06 - "T4 levels varied significantly
between all of the groups, with the shorter-lived groups having higher
levels of T4 than longer-lived groups ... However, because T3, levels did
not differ significantly among all the groups, further research in this area
using larger sample sizes (numbers of rodents in each group) is needed"
- Thyroid
Supplementation Enhances Antidepressant Response - Medscape, 9/21/06 -
"Remission occurred in 31 patients (58.5%) receiving T3 compared with 19
patients (38%) in the placebo group"
-
T3 Therapy Not Yet Ready for Psychiatric Use - Clinical Psychiatry News,
2/05 -
"Today, many patients with complaints of chronic
malaise or fatigue approach their physician seeking T3 therapy, but the fact
is that none of the handful of well-designed randomized controlled trials
done since then has been able to confirm the initial report of superior
outcomes ... There is reason for concern that supraphysiologic doses of T3
in this setting could interfere with protein and fat metabolism and interact
synergistically with catecholamines to increase myocardial oxygen demand,
with resultant increased arrhythmia, MI, heart failure, and death"
-
Algorithm-Based Treatment Shows High Lack Of Response To Selective Serotonin
Reuptake Inhibitors - Doctor's Guide, 4/17/03 -
"When the clinicians added T3, they found it was
effective among 10 out of 16 women patients (62.5%), but was not effective
in any of the 9 male patients who received it. Although values were within
the normal range, patients who responded to T3 had higher serum
thyroid-stimulating hormone levels than those who did not ... The effect of
T3 may be related to thyroid function even within the normal range"
- Options for
Treatment-Resistant Depression - Psychiatric Times, 7/02 -
"Use of T3 may interfere with thyroid metabolism if
taken chronically, so its use should generally be limited to two or three
weeks. Doses of T3 between 25 mcg/day to 50 mcg/day are more effective than
T4"
-
Bipolar Patients Sensitive to Thyroid Function Variations - Doctor's
Guide, 1/8/02 -
"They studied 65 patients in the depressed phase of
bipolar I disorder to test the hypothesis that patients with lower thyroid
function, even within the normal range, might have a poorer response to
treatment initially ... Outcomes were relatively poor unless patients had
FTI [free thyroxine index] values above the median and TSH values below the
median"
-
Does thyroid supplementation accelerate tricyclic antidepressant response? A
review and meta-analysis of the literature - Am J Psychiatry 2001
Oct;158(10):1617-22 - "This meta-analysis supports
the efficacy of T(3) in accelerating clinical response to tricyclic
antidepressants in patients with nonrefractory depression"
- Sustained
Release T3 / Time Release T3 - WilsonSyndrome.com -
"When Dr. Wilson first started treating Wilson's
Thyroid Syndrome, Cytomel (instant release) was all he used. When he had
about 300 patients at a time on Cytomel, he would get about 6-8 beeper pages
over the weekend from patients having complaints and 2-3 of those calls
would be about some pretty worrisome side effects. When Dr. Wilson conceived
of and started using T3 mixed with a sustained release agent (see WTS
history) he would go 6 months without a page"
- Synthroid
/ Armour Thyroid - WilsonSyndrome.com -
"Some patients and physicians hear about the need
for T3 and think they can gain the benefits of T3 by using Armour instead of
Synthroid because it contains T3. But Armour thyroid doesn't contain just
T3. It contains a lot of T4 as well! T4 is the very hormone we're trying to
reduce in WTS in order to deplete RT3 levels"
-
Thyroid Hormones Accelerate Depressive Response to Drug Therapy -
Doctor's Guide, 10/30/01 -
"Five of the six studies found T3 to be
significantly more effective than placebo in accelerating clinical response
... Investigators say they found that the average effect was highly
significant"
-
The acute effect of calcium carbonate on the intestinal absorption of
levothyroxine - Thyroid 2001 Oct;11(10):967-71 -
"When 1,000 microg of levothyroxine alone was given
to subjects, the maximum average total T4 absorption was 837 microg (83.7%
of the dose ingested) at 120 minutes. When levothyroxine was coadministered
with 2.0 g of calcium (as calcium carbonate), the maximum average T4
absorption decreased to 579 microg (57.9% of the dose ingested) at 240
minutes"
- Use OF T3 Thyroid
Hormone to Treat Depression - DrMirkin.com, 5/19/01 -
"some people become depressed when they take just T4
and their depression can be cured when they take both thyroid hormones, T3
and T4"
-
Replacing T4 With Triiodothyronine Improves Cognition And Mood In
Hypothyroidism - Doctor's Guide, 7/5/00 -
"Substituting T3 for a portion of T4 changed the
concentrations of thyroid hormones and thyroid-stimulating hormone (TSH) as
well as improving cognition and mood"
-
T3---fibromyalgia, hypothyroidism, thyroid hormone resistance -
drlowe.com
- Wilson's
Thyroid Syndrome -
"Conversion of T4 to T3 can also be impaired by
glucocorticoids" - Maybe that is the mechanism by which
cortisol causes depression, and if so, could
T3 then cure the depression? - Ben
- Adding Natural Hormone
Boosts Brain Function In Hypothyroidism - Doctor's Guide, 2/11/99 -
"We found there wasn't much difference between the
two treatments in terms of metabolic effects or effects on various
peripheral organs," Prange said. "There were big differences, however, in
the mental state of the patients. If these findings hold up, they will be
very important."
-
Depression Management - ContinuingEducation.com, exp. 12/31/02 - See
table six, recommends 5 - 50 mcg T3, 100 mcg (.1 mg) T4
-
Liothyronine Sodium - RxList.com -
"Twenty-five mcg of liothyronine [T3] is equivalent
to approximately 1 gram of desiccated thyroid or thyroglobulin and 0.1 mg of
L-thyroxine [T4]" - I don't know if that is correct concerning 1 gram
of desiccated thyroid. That would mean that it would take 17 of the normal
60 mg desiccated thyroid capsules to equal 25 mcg T3 and 100 mcg T4 (1000/60
= 17). I would think that that amount would be lethal. Maybe it should
have been grains instead of grams. Any feedback would be appreciated. - Ben
Abstracts:
-
Low T3 syndrome upon
admission and response to nutritional support in malnourished medical inpatients
- J Clin Endocrinol Metab 2022 Dec 22 - "We had complete
data including fT3 concentration of 801/2028 (39.5%) patients from the initial
trial. Of these 492 (61.4%) had low T3 syndrome (fT3 < 3.2 pmol/l). Low T3
syndrome was associated with higher mortality over 30 days (adjusted hazard
ratio 1.97 [95%CI 1.17 to 3.31], p 0.011) and other adverse clinical outcomes"
- Note: Yet with all the studies supporting T4/T3 combinations, if you ask and
old time/good ole boy, endocrinologist for the T4/T3 combo, they react like your
asking for a prescription for cocaine. They seem to have an attitude that
they're god and that they don't need to read no studies.
-
A decrease in peripheral
thyroid hormone conversion efficiency in patients treated with immune checkpoint
inhibitors and L-T3 as a possible alternative therapeutic escape option -
Eur J Clin Invest 2022 Apr 15 - "Hypothyroidism is a
frequently occurring side effect in patients under treatment with immune
checkpoint inhibitors (ICIs) ... Recently, we were rarely confronted with a
clinically overt hypothyroidism in three patients under treatment with ICIs who
were non-responsive to T4 therapy. As a therapeutical escape, liothyronine
(L-T3) was started with a significant clinical and/or biochemical improvement
suggesting an underlying functional defect in the peripheral free T4 (fT4) to
free T3 (fT3) conversion (as supported by calculation of SPINA-GD)"
- Note: Many people take amiodarone to treat heart rhythm problems. Amiodarone
also blocks the conversion of T4 to T3 and by taking T4 alone, your T4 can get
too high while you TSH is also high. I feel that the solution is a combination
of T4 and T3. I've had an grumpy old-timer endocrinologist that should have
retired a long time ago disagree with me so I found another one. Don't let them
gas-light or lie to you. Show them the studies. There's a study on one of my
pages showing that high T4 with normal TSH can contribute to arrhythmias plus
I've had an E.R. doctor tell me that.
-
Higher free triiodothyronine
is associated with higher HDL particle concentration and smaller HDL particle
size - J Clin Endocrinol Metab 2022 Feb 2 - "In
euthyroid individuals, higher FT3 is cross-sectionally associated with higher
total HDL particle concentration and with lower HDL particle size. These
associations may be relevant to better understand the role of HDL in thyroid
function-associated atherosclerotic cardiovascular disease"
-
Associations
among FT 4 level, FT 3/FT 4 ratio, and non-alcoholic fatty liver
disease in Chinese patients with hypopituitarism - Endocr J
2022 Jan 14 - "The NAFLD(+) group had a
significantly higher free triiodothyronine/free thyroxine
(FT3/FT4) ratio than the NAFLD(-) group (p = 0.003). The
NAFLD(+) group showed significantly lower levels of FT4 and the
growth hormone (GH) than the NAFLD(-) group (p = 0.003 and
0.016, respectively). We observed an association of the FT4
level and FT3/FT4 ratio with NAFLD in the univariate model,
which was non-significant after adjustment for metabolic
parameters (BMI, HDL-C, triglycerides, serum uric acid, blood
pressure, fasting glucose). To better understand the role of
each metabolic parameters, we performed additional models for
each of those predictors individually after adjustment for age
and gender, the association between FT4 level and FT3/FT4 ratio
lost significance after adjustment for HDL-C and TG, but not for
other predictors. Our findings suggest that thyroid dysfunction
may be crucially involved in NAFLD by regulating whole-body
metabolism, especially lipid utilization. Therefore, sufficient
thyroid hormone replacement therapy for patients with
hypopituitarism is recommended from the early stage"
-
Does the FT3-to-FT4 ratio
easily predict the progression of NAFLD and NASH cirrhosis? - J Int Med Res
2021 Nov - "In patients with biopsy-proven NAFLD, the FT3-to-FT4 ratio was
significantly lower than in the healthy group"
-
Free triiodothyronine /free
thyroxine ratio as an index of deiodinase type 1 and 2 activities negatively
correlates with casual serum insulin levels in patients with type 2 diabetes
mellitus - Endocr J 2021 May 11 - "Free
triiodothyronine/free thyroxine (FT3/FT4) ratio is considered as an index of the
activities of iodothyronine deiodinase types 1 and 2 (DIO1 and DIO2,
respectively) and is reportedly associated with insulin resistance in euthyroid
adult ... The FT3/FT4 ratio was independently associated with
thyroid-stimulating hormone, casual plasma glucose, and casual insulin levels.
In terms of the regression coefficients of the univariate linear regression
analysis, the FT3/FT4 ratio negatively correlated with the casual serum insulin
levels. Therefore, the risk of FT3/FT4 ratio underestimation should be
considered when diagnosing Graves' disease, which is often accompanied with
insulin resistance"
-
Serum Free Triiodothyronine
and the Responsiveness to Clopidogrel in Patients Undergoing Elective
Percutaneous Coronary Intervention - Adv Ther 2021 Apr 29 -
"percutaneous coronary intervention (PCI) ... Low FT3
was independently associated with increased risks of both low responsiveness to
clopidogrel and cardiovascular events in patients undergoing elective PCI"
-
Low Free Triiodothyronine
Level as a Predictor of Cardiovascular Events and All-Cause Mortality in
Patients Undergoing Hemodialysis: The DREAM Cohort - J Atheroscler Thromb
2020 Dec 23 - "Low T3 syndrome is characterized by low
serum triiodothyronine (T3) levels without elevation of thyroid-stimulating
hormone (TSH) in patients without apparent thyroid disease, which is known to be
associated with worse clinical outcomes in various populations including those
with kidney failure ... We analyzed data from 438 eligible patients. During the
5-year follow-up, 154 new CVD events and 86 all-cause deaths were recorded.
Kaplan-Meier analysis showed that lower FT3 levels were associated with higher
risks for new cardiovascular events and all-cause death. This inverse
association of FT3 and new CVD events remained significant after adjustment for
age, sex, duration of hemodialysis, diabetic kidney disease, hypertension,
dyslipidemia, and smoking; however, it was no longer significant after further
adjustment for prior CVD or N-terminal fragment of probrain natriuretic peptide
(NT-proBNP). FT3 did not show an independent association with all-cause
mortality ... Our results indicate that low FT3 status is not an independent
predictor of new CVD events and that the following factors are closely
associated: prior CVD, low FT3 and high NT-proBNP levels at present, and future
risk of new CVD events in hemodialysis patients"
-
Free T3 to free T4 ratio
less than 2.0 suggests low T3 syndrome rather than central hypothyroidism from
the age of two to eighteen years - Endocr J. 2016 Dec 22 -
"No serological cut-off exists to separate low T3
syndrome (LT) and central hypothyroidism (CH) ... In conclusion, fT3/fT4 less
than 2.0 suggests LT rather than CH for patients from the age of two to eighteen
years"
-
Waist-to-Height Gain and
Triiodothyronine Concentrations in a Cohort of Socially Vulnerable Short-Stature
Women: A Four-Year Follow-Up Study - Ann Nutr Metab. 2016 Jun
28;68(4):298-305 - "Women of short stature presented an
increase in waist-to-height ratio, with a simultaneous decrease in total plasma
T3. These alterations may lead them to increased risk of comorbidities"
-
3,3',5-triiodothyroxine inhibits apoptosis and oxidative stress by the PKM2/PKM1
ratio during oxygen-glucose deprivation/reperfusion AC16 and HCM-a cells -
Biochem Biophys Res Commun. 2016 May 6 - "Oxidative
stress (OS) plays a crucial role in the development of myocardial disease, which
can induce the dysfunction of cardiac muscle cells ... The present study aimed
to reveal the key effects of T3 on protecting human myocardial cell lines from
oxidative stress and the downstream molecular mechanism ... The effects of T4
were not notable. T3 also protected OGDR cells from apoptosis and upregulated
the PKM2/PKM1 ratio"
-
TSH
enhancement of FT4 to FT3 conversion is age dependent - Eur J Endocrinol.
2016 May 5 - "This may reflect a decrease in Thyroxine
(T4) to Triiodothyronine (T3) conversion with age, which may be part of the
ageing process"
-
Tri-iodothyronine
preconditioning protects against liver ischemia reperfusion injury through the
regulation of autophagy by the MEK/ERK/mTORC1 axis - Biochem Biophys Res
Commun. 2015 Oct 20 - "After 70% liver ischemia
reperfusion injury, mice that were preconditioned with appropriate T3 displayed
significantly preserved liver function, less histological damage, less
apoptosis, and enhanced antioxidant capacity ... T3 preconditioning could be a
potential therapeutic approach to prevent liver IR injury related to various
clinical conditions"
-
Free
Triiodothyronine Concentrations are Inversely Associated with Elevated Carotid
Intima-Media Thickness in Middle-Aged and Elderly Chinese Population - J
Atheroscler Thromb. 2015 Oct 1 - "Multivariate-adjusted
logistic regression analysis showed that high FT3 levels were associated with
low prevalent elevated C-IMT. The adjusted odds ratio for elevated C-IMT was
0.71 (95% confidence interval, 0.52-0.99, P=0.04) when comparing the highest
with the lowest quartile of FT3"
-
Positive
association of free triiodothyronine with pancreatic β-cell function in people
with prediabetes - Diabet Med. 2014 Sep 26 - "Free
triiodothyronine is associated with both basal and glucose-stimulated insulin
secretion in people with prediabetes who are euthyroid; therefore, the
regulation of insulin secretion by thyroid hormones is a potentially novel
therapeutic target for the treatment of diabetes"
-
Defending
Plasma T3 is a Biological Priority - Clin Endocrinol (Oxf). 2014 Jul 5 -
"Studies in rodents indicate that different levels of
genetic disruption of the feedback mechanism and deiodinase system are met with
elevation in serum T4 and thyroid stimulating hormone (TSH) levels, while serum
T3 levels remain stable. These findings have focused attention on serum T3
levels in patients with thyroid disease, with important clinical implications
affecting therapeutic goals and choice of therapy for patients with
hypothyroidism. Although monotherapy with levothyroxine is the standard of care
for hypothyroidism, not all patients normalize serum T3 levels with many
advocating for combination therapy with levothyroxine and liothyronine. The
latter could be relevant for a significant number of patients that remain
symptomatic on monotherapy with levothyroxine, despite normalization of serum
TSH levels"
-
Serum free
thyroxine levels are positively associated with arterial stiffness in the
SardiNIA study - Clin Endocrinol (Oxf). 2014 Jun 23 -
"Like several other known risk factors, serum FT4 levels
are associated with carotid-femoral pulse wave velocity, suggesting that high
FT4 levels have a detrimental effect on aortic stiffness and may contribute to
aging process of the vascular system. This finding may help to understand the
pathogenesis of cardiovascular disease and contribute to improve prevention
therapy"
-
Increases in
Thyrotropin Within the Near-Normal Range Are Associated With Increased
Triiodothyronine But Not Increased Thyroxine in the Pediatric Age Group - J
Clin Endocrinol Metab. 2014 May 30:jc20141441 - "Within
the near-euthyroid range, increasing TSH levels are associated with increasing
FT3 levels, without an increase in FT4. This provides in vivo support for TSH
enhancing preferentially T3 production and/or secretion"
-
Associations
between thyroid function and mortality: the influence of age - Eur J
Endocrinol. 2014 May 6 - "AS FOR THYROID FUNCTION WITHIN
THE NORMAL RANGE: in the 493 participants aged 80 years or older, a FT4 level in
the high-normal range (18.5-22 pmol/l) was associated with a higher mortality in
comparison to FT4 levels in the middle range (11.5-15.0 pmol/L): HR 1.7 (95% CI
1.0-2.9). In these elderly, also TSH levels within the high-normal range
(3.0-4.0 mIU/L) were associated with a higher mortality in comparison to TSH
levels within the middle range (1.0-2.0 mIU/L)" - Note: That would
seem to support the need to replace some of the T4 with T3. T4 will reduce
TSH. If increasing T4 increases mortality yet you want to get you TSH down
between 1.0 and 2.0 then the only way to do it without increasing T4 is with
T3.
-
Impact of
Triiodothyronine and N-Terminal Pro-B-Type Natriuretic Peptide on the Long-Term
Survival of Critically Ill Patients With Acute Heart Failure - Am J Cardiol.
2013 Dec 12 - "Based on cut-off values for NT-proBNP
(10,685 pg/ml) and T3 (52.3 ng/dl), Kaplan-Meier analyses provided significant
prognostic information with the highest risk for all-cause mortality in the low
T3 (≤52.3 ng/dl)/high NT-proBNP (>10,685 pg/ml) group (HR 8.54, 95% CI 4.19 to
17.40, p <0.0001). In conclusion, T3 levels appear to be independent predictors
for both all-cause and cardiac mortalities among critical ill patients with
heart failure, and high NT-proBNP and low T3 levels predict a worse long-term
outcome"
-
Fatigue in patients with
coronary artery disease: association with thyroid axis hormones and cortisol
- Psychosom Med. 2012 Oct;74(8):848-53 - "In univariate
regression analysis, lower free T(4) concentrations were associated with general
and exertion fatigue, lower free T(3) concentrations were associated with
general and physical fatigue, and lower ΔCortisol was associated with mental
fatigue"
-
Higher Free
Thyroxine Levels Predict Increased Incidence of Dementia in Older Men: The
Health In Men Study - J Clin Endocrinol Metab. 2012 Sep 13 -
"Men who developed dementia had higher baseline FT(4)
(16.5 +/- 2.2 vs. 15.9 +/- 2.2 pmol/liter, P = 0.004) but similar TSH (2.2 +/-
1.4 vs. 2.3 +/- 1.6 mU/liter, P = 0.23) compared with men who did not receive
this diagnosis. After adjusting for covariates, higher FT(4) predicted new-onset
dementia (11% increased risk per 1 pmol/liter increase in FT(4), P = 0.005;
quartiles Q2-4 vs. Q1: adjusted hazard ratio = 1.76, 95% confidence interval =
1.03-3.00, P = 0.04). There was no association between TSH quartiles and
incident dementia. When the analysis was restricted to euthyroid men (excluding
those with subclinical hyper- or hypothyroidism), higher FT(4) remained
associated with incident dementia (11% increase per unit increment, P = 0.03;
Q2-4 vs. Q1: adjusted hazard ratio = 2.02, 95% confidence interval = 1.10-3.71,
P = 0.024)" - Note: There is also an association with a low T3/T4
ration and insulin resistance. I alternate between taking T4 on day and T3 the
next. Doctor's seem to refuse to prescribe both.
-
Hyperinsulinemia and insulin resistance is associated with low T(3)/T(4)
ratio in pre diabetic euthyroid pakistani subjects - J Diabetes
Complications. 2012 Jul 11 - "Hyperinsulinemia and
insulin resistance are associated with low T(3)/T(4) ratio in pre-diabetic
euthyroid Pakistani subjects"
-
Familial
Longevity Is Associated with Decreased Thyroid Function - J Clin Endocrinol
Metab. 2010 Aug 25 - "We found that a lower family
mortality history score (less mortality) of the parents of nonagenarian siblings
was associated with higher serum TSH levels (P = 0.005) and lower free T4 levels
(P = 0.002) as well as lower free T3 levels (P = 0.034) in the nonagenarian
siblings"
-
T3 affects
expression of collagen I and collagen cross-linking in bone cell cultures -
Biochem Biophys Res Commun. 2010 Aug 10 - "T3 increased
mRNA expressions of procollagen-lysine-1,2-oxoglutarate 5-dioxygenase 2 (Plod2)
and of lysyloxidase (Lox), both genes involved in post-translational
modification of collagen. Moreover, it stimulated mRNA expression of BMP-1, the
processing enzyme of the lysyloxidase-precursor and of procollagen. An increase
in the collagen cross-link-ratio Pyr/deDHLNL indicates, that T3 modulated
cross-link maturation in the MC3T3-E1 culture system. These results demonstrate
that T3 directly regulates collagen synthesis and collagen cross-linking by
up-regulating gene expression of the specific cross-link related enzymes, and
underlines the importance of a well-balanced concentration of thyroid hormones
for maintenance of bone quality"
-
The
pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized,
double blind, cross-over study in thyroidectomized patients - Clin
Endocrinol (Oxf). 2010 May;72(5):709-15 - "This is the
first study addressing the equivalency between L-T3 and L-T4 therapy measured by
baseline and TRH-stimulated TSH. The therapeutic substitution of L-T3 for L-T4
was achieved at approximately 1:3 ratio"
-
The
pharmacodynamic equivalence of levothyroxine and liothyronine. A randomized,
double blind, cross-over study in thyroidectomized patients - Clin
Endocrinol (Oxf). 2009 Sep 10 - "The therapeutic
substitution of L-T3 for L-T4 was achieved at approximately 1:3 ratio"
-
Increased
reverse T3 is associated with shorter survival in independently-living elderly.
The Alsanut study - Eur J Endocrinol. 2008 Nov 10 -
"rT3 was the only thyroid hormone associated with shorter survival"
-
Higher Serum Free Thyroxine Levels Are Associated with Coronary Artery Disease
- Endocr J. 2008 May 23 - "The relative risk (RR) for
CAD in highest tertile of FT(4 )showed increased risk compared with the lowest
tertile (RR 1.98; 95% CI 0.98-3.99, p<0.001). Our study showed that FT(4 )levels
were associated with the presence and the severity of CAD. Also, this study
suggests that elevated serum FT(4 )levels even within normal range could be a
risk factor for CAD" - That might be an argument for going with T4 on say
even days and T3 on odd days.
-
ACUTE EFFECTS OF TRIIODOTHYRONINE REPLACEMENT THERAPY IN PATIENTS WITH
CHRONIC HEART FAILURE AND LOW-T3 SYNDROME: A RANDOMIZED, PLACEBO-CONTROLLED
STUDY - J Clin Endocrinol Metab. 2008 Jan 2 -
"Low-triiodothyronine (T3) syndrome is a predictor of poor outcome in
patients with cardiac dysfunction ... dilated cardiomyopathy (DC) ... In DC
patients, short-term synthetic L-T3 replacement therapy significantly
improved neuroendocrine profile and ventricular performance"
-
Low triiodothyronine: a strong predictor of outcome in acute stroke patients
- Eur J Clin Invest. 2007 Aug;37(8):651-7 - "The
1-year mortality was 27.34% for low T3 and 19.37% for normal T3 cases (P =
0.006). A smaller percentage of patients with low T3 values were independent
at 1 year compared to those with normal T3 values [54.2% vs. 68.7%, chi(2) =
12.09, P < 0.001, odds ratio (OR) = 0.53"
-
Free triiodothyronine and thyroid stimulating hormone are directly
associated with waist circumference, independently of insulin resistance,
metabolic parameters and blood pressure in overweight and obese women -
Clin Endocrinol (Oxf). 2007 Jun 4
-
A Comparison of Lithium and T3 Augmentation Following Two Failed Medication
Treatments for Depression: A STAR*D Report - Am J Psychiatry. 2006
Sep;163(9):1519-30 - "After a mean of 9.6 weeks
(SD=5.2) of treatment, remission rates were 15.9% with lithium augmentation
and 24.7% with T(3) augmentation"
-
T3 augmentation of SSRI resistant depression - J Affect Disord. 2006
Apr;91(2-3):211-5 - "The women took a mean daily
dose of 40.6 mug of T3 for a mean duration of 3.75 weeks, while the men were
on a mean daily dose of 43.8 mug of T3 for 3.5 weeks. T3 augmentation was
associated with a statistically significant drop (p<.003) in the mean HAMD
at end of the three weeks compared to baseline scores"
-
Critical appraisal: Combined T3 and T4 replacement therapy is not better
than replacement with T4 alone - Rev Med Chil. 2005 Sep;133(9):1116-9
-
Natural killer activity and thyroid hormone levels in young and elderly
persons - Gerontology 2001 Sep-Oct;47(5):282-8 -
"Decreased serum concentrations of total T(3) may
contribute to low NK activity in the 'almost healthy' subgroup of the
elderly"
-
Effect of triiodothyronine on mitochondrial energy coupling in human
skeletal muscle - J Clin Invest 2001 Sep;108(5):733-7 -
"these data suggest that T(3) promotes increased
thermogenesis in part by promoting mitochondrial energy uncoupling in
skeletal muscle"
-
Topical triiodothyronine stimulates epidermal proliferation, dermal
thickening, and hair growth in mice and rats - Thyroid 2001
Aug;11(8):717-24 -
"hair length that was 1,180% longer ... 85% more
hairs per millimeter ... topically applied thyroid hormone has dramatic
effects on both skin and hair growth. These observations offer a new
strategy for developing thyroid hormone and its analogues for treating
disorders of skin and hair growth"
-
Does low tri-iodothyronine independently predict mortality in elderly
hospitalised patients? - Int J Clin Pract 2001 Jul-Aug;55(6):409-10 -
"Our study shows an association of low serum T3 with
patient mortality in elderly hospitalised patients"
-
Thyroid Hormone Replacement Therapy - Horm Res 2001 Jan;56 Suppl
S1:74-81 -
"Desiccated thyroid contains both thyroxine (T(4))
and triiodothyronine (T(3)); serum T(3) frequently rises to supranormal
values in the absorption phase, associated with palpitations. Liothyronine
(T(3)) has the same drawback and requires twice-daily administration in view
of its short half-life ... TSH values of </=0.1 mU/l carry a risk of
development of atrial fibrillation and are associated with bone loss
although not with a higher fracture rate. It is thus advisable not to allow
TSH to fall below - arbitrarily - 0.2 mU/l ... recent animal experiments
indicate that only the combination of T(4) and T(3) replacement, and not
T(4) alone, ensures euthyroidism [normal
thyroid status] in all tissues of thyroidectomized rats ... It could
well be that a slow-release preparation containing both T(4) and T(3) might
improve the quality of life, compared with T(4) replacement alone, in some
hypothyroid patients"
-
Effects of thyroxine as compared with thyroxine plus triiodothyronine in
patients with hypothyroidism - N Engl J Med. 1999 Feb 11;340(6):469-70 -
"among 15 visual-analogue scales used to indicate
mood and physical status, the results for 10 were significantly better after
treatment with thyroxine [t4] plus triiodothyronine [t3]"
|
|